Oruka Therapeutics Stock Forecast

Stock Price Forecast

The 12 analysts with 12-month price forecasts for Oruka Therapeutics stock have an average target of 88.33, with a low estimate of 45 and a high estimate of 160. The average target predicts an increase of 19.38% from the current stock price of 73.99.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$45	$88.33	$85	$160
Change	-39.18%	+19.38%	+14.88%	+116.25%

Analyst Ratings

The average analyst rating for Oruka Therapeutics stock from 12 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Nov '25	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26
Strong Buy	6	6	7	7	8	8
Buy	3	4	4	4	4	4
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	9	10	11	11	12	12

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Michael Yee UBS	UBS	Strong Buy Maintains $75 → $100	Strong Buy	Maintains	$75 → $100	+35.15%	Apr 28, 2026
Etzer Darout Barclays	Barclays	Buy Maintains $78 → $160	Buy	Maintains	$78 → $160	+116.25%	Apr 28, 2026
Julian Harrison BTIG	BTIG	Strong Buy Maintains $78 → $151	Strong Buy	Maintains	$78 → $151	+104.08%	Apr 27, 2026
Martin Fan Wedbush	Wedbush	Buy Maintains $45 → $85	Buy	Maintains	$45 → $85	+14.88%	Apr 15, 2026
Yatin Suneja Guggenheim	Guggenheim	Strong Buy Reiterates $125	Strong Buy	Reiterates	$125	+68.94%	Apr 13, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

n/a

EPS This Year

-2.40

from -1.85

EPS Next Year

-2.79

from -2.40

Fiscal Year	FY 2024	FY 2025	FY 2026	FY 2027	FY 2028	FY 2029	FY 2030
Period Ending	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027	Dec 31, 2028	Dec 31, 2029	Dec 31, 2030
Revenue	-	-	-	-	-	-	40.97M
Revenue Growth	-	-	-	-	-	-	-
EPS	-4.23	-1.85	-2.40	-2.79	-3.39	-4.01	-4.51
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	14	13	10	7	7

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	n/a	n/a
Avg	n/a	n/a
Low	n/a	n/a

Revenue Growth

Revenue Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

EPS Forecast

EPS	2026	2027
High	-2.02	-1.81
Avg	-2.40	-2.79
Low	-3.10	-3.62

EPS Growth

EPS Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.